BioSpace News Archive

Vioguard, Inc., the industry leader in ultraviolet light disinfecting solutions, today announced Brian Mitchell has joined the company as Vice President of Sales. His role will support the need for Viogu

MaaT Pharma announced today it plans to initiate a new collection and manufacturing campaign to be completed in the second half of 2020 for the production of its microbiome biotherapeutics, enema formulation MaaT013 and capsule formulation MaaT033.

Newtopia Inc. (TSXV: NEWU), a tech-enabled disease prevention company focused on healthy habit change, today announced it is offering an expanded product suite that targets hypertension, type 2 diabetes and weight

Daré Bioscience, Inc. (NASDAQ:DARE), a leader in women’s health innovation, today announced the publication of a proof of concept study of DARE-BV1 in Clinical and Experimental Obstetrics & Gynecology, an international journal focused on publication of high quality scientific research related to obstetrics and gynecology and women’s health.

Furthering its commitment to deliver the benefits of simple, high viability cell sorting solutions globally, NanoCellect Biomedical announced it has completed agreements with several key partners to distribute its WOLF

In a significantly oversubscribed offering, Science 37 attracted capital to support its rapid growth, expand its technology platform and accelerate global expansion. [20-August-2020] LOS ANGELES , Aug. 20, 2020 /PRNewswire/ -- Science 37, the industry leader in decentralized clinical trials, today announced it closed an oversubscribed $40 million funding round. Exis

NimbleRx, a platform providing independent pharmacies the ability to offer convenient, online delivery, announced a partnership with Uber Health to offer safe, contactless prescription delivery from pharmacies in Seattle, WA and Dallas, TX, and soon, other parts of the country.

-- $3 million milestone payment for U.S. approval of OLINVYK™ (oliceridine) injection Additional approval and commercialization milestone payments expected as well as 10% royalties on net sales in China -- CHESTERBROOK, Pa., Aug. 20, 2020 (GLOBE NEWSWIRE) -- Trevena, Inc. (Nasdaq: TRVN) , a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced it has a received a $3

CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a biopharmaceutical company focused on developing and providing access to innovative therapies for patients with liver and other chronic diseases, today announced that two seladelpar presentations will be delivered during the Digital International Liver Congress™ 2020 of the European Association for the Study of Liver (EASL) which will be held online August 27 th – 29 th . The presentation titled “D

Axcella (Nasdaq: AXLA), a clinical-stage biotechnology company focused on leveraging endogenous metabolic modulators (EMMs) to pioneer a new approach for treating complex diseases and improving health, today announced an upcoming late-breaker poster presentation at The Digital International Liver Congress™ 2020 (EASL), which is being held virtually from August 27 to 29. This presentation will discuss key data from A